Log in to save to my catalogue

Omega‐3 blood biomarkers relate to brain glucose uptake in individuals at risk of Alzheimer's diseas...

Omega‐3 blood biomarkers relate to brain glucose uptake in individuals at risk of Alzheimer's diseas...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_55094da86e9a4f2ebabfe33b7f5036b9

Omega‐3 blood biomarkers relate to brain glucose uptake in individuals at risk of Alzheimer's disease dementia

About this item

Full title

Omega‐3 blood biomarkers relate to brain glucose uptake in individuals at risk of Alzheimer's disease dementia

Publisher

United States: John Wiley & Sons, Inc

Journal title

Alzheimer's & dementia : diagnosis, assessment & disease monitoring, 2024-07, Vol.16 (3), p.e12596-n/a

Language

English

Formats

Publication information

Publisher

United States: John Wiley & Sons, Inc

More information

Scope and Contents

Contents

INTRODUCTION
Brain glucose hypometabolism is a preclinical feature of Alzheimer's disease (AD). Dietary omega‐3 fatty acids promote brain glucose metabolism, but clinical research is incipient. Circulating omega‐3s objectively reflect their dietary intake.
METHODS
This was a cross‐sectional study in 320 cognitively unimpaired participants...

Alternative Titles

Full title

Omega‐3 blood biomarkers relate to brain glucose uptake in individuals at risk of Alzheimer's disease dementia

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_55094da86e9a4f2ebabfe33b7f5036b9

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_55094da86e9a4f2ebabfe33b7f5036b9

Other Identifiers

ISSN

2352-8729

E-ISSN

2352-8729

DOI

10.1002/dad2.12596

How to access this item